Infectious Disease
115
19
21
63
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Published Results
12 trials with published results (10%)
Research Maturity
63 completed trials (55% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.6%
3 terminated out of 115 trials
95.5%
+8.9% vs benchmark
7%
8 trials in Phase 3/4
19%
12 of 63 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 63 completed trials
Clinical Trials (115)
Addressing Risk Through Community Treatment for Infectious Disease and Opioid Use Disorder Now (ACTION) Among Justice-involved Populations
An International Observational Study of Adults With Acute Infection
A Rapid Triage Test to Improve Risk-stratification of Febrile Children (EChiLiBRiST, Clinical Trial 1, Outpatients)
Compliant Analysis of Patient Samples and Data
A Validation Study of the Lab Clasp Device: A Point of Care Sepsis Risk Monitor
Metabolic and Infectious Diseases in La Réunion (the REUNION Population-based Study)
Genetic Susceptibility to Severe Infections
Ocular Pathogen and Transcriptome Investigation Using Comprehensive Sequencing
A Phase 1 Study to Evaluate JCXH-108, an mRNA-based Vaccine Against RSV
Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial
Contribution of a Video Support to Inform the Patient Before a Complementary Examination in Infectious Diseases
Infectious Diseases Experts as Part of the Antibiotic Stewardship Team in Primary Care
L-citrulline to Improve Adverse Outcomes in Admitted Children (EChiLiBRiST, Clinical Trial 2, Inpatients)
Evaluation of Tolerance and Pharmacokinetic Profile of High Doses of Favipiravir in Healthy Volunteers
A Single-Dose, Three-Way, Three-Sequence, Crossover BA Study of Azithromycin Oleogel
Beta-lactams Therapeutic Drug Monitoring in Critically Ill Patients
CytOSorb TreatMent Of Critically Ill PatientS Registry
Cancer: Rapid Diagnostics and Immune Assessment for SARS-CoV-2 (COVID-19)
Vitality in Infants Via Azithromycin for Neonates Trial
Antibiotic Therapy in Viral Airway Infections